Search results

Narrow your search

Result types

Showing 121 - 130 of 186 for "Pharmaceuticals%20and%20life%20sciences" with applied filters

News & Analysis

The Future of the Food Industry: Food Tech

27 July 2023 by Lee & Ko

With significant development in dietary supplements and alternative food industry in recent years, Korean government announced alternative food (e.g., plant-based meet, cultured meat, insect based meat, etc.), dietary supplement and medical food (i.e., specially formulated food for patients with certain symptoms or nutritional needs) as industry sectors for future development.

News & Analysis

mRNA Vaccines: A Breakthrough Technology

11 July 2023 by LexOrbis - India: Manisha Singh (Partner) & Vaneet Kaur (Senior Associate)

RNA molecules have been utilized as therapeutic and research tools for more than two decades, with the usage ranging from in vitro transcribed (IVT) mRNA, small interference RNA (siRNA), RNA aptamers, riboswitches, and antisense RNA to the recently developed mRNA vaccines.

News & Analysis

Product Hopping and Ever-Greening of Patents in India

20 April 2023 by LexOrbis - Arun Kumar (Managing associate)

The Indian pharmaceutical market is one of the largest markets in the globe, both in terms of production and consumption. Several changes have been made to the patent and competition law due to the increasing challenges in the pharmaceutical market that directly impact the profit margin of pharmaceutical manufacturers. To increase these margins, pharmaceutical product manufacturing firms employ a variety of strategies. This article investigates the concept of “product hopping” and compares it with the practice of patent evergreening.

News & Analysis

Resolving the conflict between section 3(d) and section 3(e)

23 March 2023 by LexOrbis - DPS Parmar

It is generally known and understood that every exception in the act should stand on its own footing. Two seemingly similar provisions in legal sense cannot lean back on one another to fortify the argument favouring the exception or otherwise. This seemingly sound argument suffers the close scrutiny of the Delhi High court in Best Agrolife Limited v Deputy Controller of Patents & Anr (WP(C)-IPD 11/2022 & CM 32/2022, 54/2022, 55/2022).

News & Analysis

India: Contemnor to pay INR 2 Crores to the plaintiffs in a patent infringement case

02 February 2023 by Anand and Anand

Pfizer Inc. and its group companies (“Pfizer”) filed a suit bearing no. CS (COMM) No. 442 of 2021 titled as Pfizer Inc. & Ors. v. Triveni Interchem Private Limited & Ors. before the Hon’ble Delhi High Court, for infringement of patent IN 218291 for the compound Palbociclib.

News & Analysis

Cocrystallization of drugs: A new hope for medical engineering

01 July 2022 by DPS Parmar [Former Technical Member (Patents), erstwhile Intellectual Property Appellate Board Special Counsel, LexOrbis]

It is known that certain crystals can coexist as supramolecular synthons. Since the discovery of the first cocrystal of urea with NaCl in 1773 a lot has changed. In 1844, the first cocrystal of the 1:1 ratio between Benzoquinone and Hydroquinone (Quinhydrone) was obtained.

News & Analysis

Amendments to the Malaysian Patents Act 1983 & Patents Regulations 1986

30 April 2022 by Shearn Delamore & Co

Amendments have been made to the Patents Act 1983 (“PA1983”) and Patent Regulations 1986 (“PR1986”), via the Patents (Amendment) Act 2022 (“the Amending Act”) and Patents (Amendment) Regulations 2022 (“the Amending Regulations”).

News & Analysis

Patent Application Filing Trend in India

12 April 2022 by Ms. Manisha Singh (Partner) and Dr. Niharika Kumaria (Managing Associate)

The world is facing the wave of coronavirus disease (Covid-19) yet there is an improvement in intellectual property (IP) filing in India with a 6% increase in application for patents and 15% in trademarks.

News & Analysis

Knowledge capital: Speaking of Wolves and vultures!

04 February 2022 by DPS Parmar [Former Technical Member (Patents), erstwhile Intellectual Property Appellate Board Special Counsel, LexOrbis]

Knowledge capital of an entity dependents on the inventive activity every inventor they hire or have.

News & Analysis

Case of Administrative Dispute over the Request for Invalidation of Trademark Right of "嘉伦光彩JIALUNGUANGCAI & DEVICE"

27 September 2021 by Beijing Gaowo Law Firm

The trademark Reg. No. 12887939 “嘉伦光彩JIALUNGUANGCAI & DEVICE” was applied for registration by Jiangsu Jialunguangcai Pharmacy Co.,Ltd. (hereinafter referred to as “Jiangsu Jialun Company”) on July 9, 2013 and approved for use in services “Pharmaceutical retail or wholesale services” on May 7, 2016.